These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32878897)

  • 1. Emergence and Magnitude of ML336 Resistance in Venezuelan Equine Encephalitis Virus Depend on the Microenvironment.
    Lee J; Parvathareddy J; Yang D; Bansal S; O'Connell K; Golden JE; Jonsson CB
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32878897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzamidine ML336 inhibits plus and minus strand RNA synthesis of Venezuelan equine encephalitis virus without affecting host RNA production.
    Skidmore AM; Adcock RS; Jonsson CB; Golden JE; Chung DH
    Antiviral Res; 2020 Feb; 174():104674. PubMed ID: 31816348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a ML336 derivative against Venezuelan and eastern equine encephalitis viruses.
    Jonsson CB; Cao X; Lee J; Gabbard JD; Chu YK; Fitzpatrick EA; Julander J; Chung DH; Stabenow J; Golden JE
    Antiviral Res; 2019 Jul; 167():25-34. PubMed ID: 30970271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.
    Chung DH; Jonsson CB; Tower NA; Chu YK; Sahin E; Golden JE; Noah JW; Schroeder CE; Sotsky JB; Sosa MI; Cramer DE; McKellip SN; Rasmussen L; White EL; Schmaljohn CS; Julander JG; Smith JM; Filone CM; Connor JH; Sakurai Y; Davey RA
    PLoS Pathog; 2014 Jun; 10(6):e1004213. PubMed ID: 24967809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venezuelan Equine Encephalitis Virus nsP3 Phosphorylation Can Be Mediated by IKKβ Kinase Activity and Abrogation of Phosphorylation Inhibits Negative-Strand Synthesis.
    Bakovic A; Bhalla N; Kortchak S; Sun C; Zhou W; Ahmed A; Risner K; Klimstra WB; Narayanan A
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32933112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-d-
    Urakova N; Kuznetsova V; Crossman DK; Sokratian A; Guthrie DB; Kolykhalov AA; Lockwood MA; Natchus MG; Crowley MR; Painter GR; Frolova EI; Frolov I
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29167335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3.
    Bakovic A; Bhalla N; Alem F; Campbell C; Zhou W; Narayanan A
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.
    Schroeder CE; Yao T; Sotsky J; Smith RA; Roy S; Chu YK; Guo H; Tower NA; Noah JW; McKellip S; Sosa M; Rasmussen L; Smith LH; White EL; Aubé J; Jonsson CB; Chung D; Golden JE
    J Med Chem; 2014 Oct; 57(20):8608-21. PubMed ID: 25244572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections.
    Ahmed A; Siman-Tov G; Keck F; Kortchak S; Bakovic A; Risner K; Lu TK; Bhalla N; de la Fuente-Nunez C; Narayanan A
    Antiviral Res; 2019 Apr; 164():61-69. PubMed ID: 30738837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcriptional landscape of Venezuelan equine encephalitis virus (TC-83) infection.
    Yao Z; Zanini F; Kumar S; Karim M; Saul S; Bhalla N; Panpradist N; Muniz A; Narayanan A; Quake SR; Einav S
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009306. PubMed ID: 33788849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of closely related epizootic and enzootic infectious cDNA clones for studying interferon sensitivity and emergence mechanisms of Venezuelan equine encephalitis virus.
    Anishchenko M; Paessler S; Greene IP; Aguilar PV; Carrara AS; Weaver SC
    J Virol; 2004 Jan; 78(1):1-8. PubMed ID: 14671082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of FDA-Approved Anti-Inflammatory Drugs Against Venezuelan Equine Encephalitis Virus Infection.
    Risner K; Ahmed A; Bakovic A; Kortchak S; Bhalla N; Narayanan A
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31842327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
    Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.
    Madsen C; Hooper I; Lundberg L; Shafagati N; Johnson A; Senina S; de la Fuente C; Hoover LI; Fredricksen BL; Dinman J; Jacobs JL; Kehn-Hall K
    Antiviral Res; 2014 Dec; 112():26-37. PubMed ID: 25448087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphaviruses.
    Lin SC; Lehman CW; Stewart AK; Panny L; Bracci N; Wright JLC; Paige M; Strangman WK; Kehn-Hall K
    Antiviral Res; 2021 Jul; 191():105087. PubMed ID: 33965437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host translation shutoff mediated by non-structural protein 2 is a critical factor in the antiviral state resistance of Venezuelan equine encephalitis virus.
    Bhalla N; Sun C; Metthew Lam LK; Gardner CL; Ryman KD; Klimstra WB
    Virology; 2016 Sep; 496():147-165. PubMed ID: 27318152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus.
    Nguyen TH; Haese NN; Madadi N; Sarkar S; Bonin K; Streblow CE; Taft-Benz S; Tower NA; Rasmussen L; Bostwick R; Augelli-Szafran CE; Suto MJ; Morrison TE; DeFilippis V; Heise MT; Streblow DN; Pathak AK
    ACS Infect Dis; 2019 Dec; 5(12):2014-2028. PubMed ID: 31257853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response.
    Ahmed A; Bakovic A; Risner K; Kortchak S; Der Torossian Torres M; de la Fuente-Nunez C; Lu T; Bhalla N; Narayanan A
    Sci Rep; 2020 Dec; 10(1):21491. PubMed ID: 33293592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-Coated Mesoporous Silica Nanoparticles for the Delivery of the ML336 Antiviral to Inhibit Encephalitic Alphavirus Infection.
    LaBauve AE; Rinker TE; Noureddine A; Serda RE; Howe JY; Sherman MB; Rasley A; Brinker CJ; Sasaki DY; Negrete OA
    Sci Rep; 2018 Sep; 8(1):13990. PubMed ID: 30228359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel antivirals inhibiting recognition of Venezuelan equine encephalitis virus capsid protein by the Importin α/β1 heterodimer through high-throughput screening.
    Thomas DR; Lundberg L; Pinkham C; Shechter S; DeBono A; Baell J; Wagstaff KM; Hick CA; Kehn-Hall K; Jans DA
    Antiviral Res; 2018 Mar; 151():8-19. PubMed ID: 29337164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.